Status: current, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3647251017 | Ertugliflozin | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3647252012 | Ertugliflozin (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ertugliflozin | Is a | Sodium glucose cotransporter subtype 2 inhibitor | true | Inferred relationship | Some | ||
| Ertugliflozin | Has disposition | Sodium glucose cotransporter subtype 2 inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ertugliflozin only product | Has active ingredient | True | Ertugliflozin | Inferred relationship | Some | 1 |
| Ertugliflozin only product in oral dose form | Has active ingredient | True | Ertugliflozin | Inferred relationship | Some | 1 |
| Ertugliflozin pidolate | Is modification of | True | Ertugliflozin | Inferred relationship | Some | |
| Ertugliflozin (as ertugliflozin pidolate) 15 mg oral tablet | Has BoSS | True | Ertugliflozin | Inferred relationship | Some | 1 |
| Ertugliflozin (as ertugliflozin pidolate) 5 mg oral tablet | Has BoSS | True | Ertugliflozin | Inferred relationship | Some | 1 |
| Allergy to ertugliflozin | Causative agent | True | Ertugliflozin | Inferred relationship | Some | 1 |
| Ertugliflozin-containing product | Has active ingredient | True | Ertugliflozin | Inferred relationship | Some | 1 |
| Ertugliflozin-containing product in oral dose form | Has active ingredient | True | Ertugliflozin | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR